1Denomme GA. The structure and function ofthe molecules that carry human red blood cell and platelet antigens[J]. Transfus Med Rev, 2004,18 (3) : 203.
2Reid ME,Mohandas N. Rod blood cell blood group antigens : stxucture and function[J]. Scmin Hematol, 2004,41 (2):93.
3McLare CA, Williom son JF, Stewart BJ, et al. Indels and imperfect duplication have driven the evolution of human complement receptor 1 (CR 1 ) and CRl-like from their pre cursor CR1 alpha:Importance of functional sets[J]. Hum Immunol, 2005,66 (3): 258.
4Craig ML, gankovieh AJ,Taylor RP. Visualization of the transfer reaction: tracking immune complexs from eryth rocyte complement receptee 1 to maerophages[J]. Clin Immunol, 2002,105 ( 1 ) : 36.
5Teixeira JE, Martinez R,Camara LM,et al. Expression of complement receptor type 1 (CR1) on erythroeytes of paracoccidiomycosis patients [J]. Mycopathologia, 2001, 152(3):125.
7Wakabayashi M,Ohi H, Tamano M, et al. Acquired loss of erythrocyte compl-ement receptor type 1 in patient with diabetic nephropathy undergoing hem-odialysis[J]. Nephron Exp Nephrol,2006,104(3) :89.
8Zaitsev S, Danielyan K, Muciano JC, et al. Human complement receptor type 1 directed loading of tissue plas minogen activator on circulating erythrocytes for prophy lactic fibrinolysis[J]. Blood, 2006,108(6) : 1895.
9Birmingham DJ, Gavit KF, McCarty SM, et al. Consump tion of erythroeyte CR1 (CD35) is association with protection against systemic lupus erythematosus renal flare [J]. Clin Exp Immunol,2006,143(2) :274.
10Arora V, Mondal AM, Grover R, et al. Modulation of CR1 transcript in systemic lupus erythematosus(SLE) by IFN gamma and immune complex [J]. Mol Immunol, 2007,44(7) : 1722.
